More than 15 years ago, Yale’s Gail D’Onofrio started studying the effectiveness of sublingual (under-the-tongue) buprenorphine for treatment of opioid use disorder (OUD) in the emergency department.
Rugiet’s ED and PE treatments are gaining attention for their science‑backed formulas and modern delivery formats. Here’s ...